NCT06061991 Mobile Instant Messaging-based Lifestyle Intervention for Gestational Diabetes Prevention
| NCT ID | NCT06061991 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Gestational Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 944 participants |
| Start Date | 2024-01-30 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 944 participants in total. It began in 2024-01-30 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomised controlled trial is to test the effectiveness of a mobile instant messaging-based lifestyle intervention in pregnant women at risk of gestational diabetes
Eligibility Criteria
Inclusion Criteria: 1. Ethnic Chinese singleton pregnant woman in \<14 weeks of gestation 2. Aged 18 years or above 3. Own a mobile phone with an instant messaging app 4. Not participating in similar trials on diabetes or lifestyle modifications 5. Have at least one of the following risk factors for GDM: * Age ≥35 years at the expected date of delivery * Body mass index (BMI) ≥ 25 kg/m2 pre-pregnancy or in the first trimester * Family history of diabetes in first-degree relative * Previous GDM or delivered a baby with birthweight ≥4 kg Exclusion Criteria: * Pre-existing diabetes or other medical conditions that may affect metabolism (e.g., thyroid disorders) or psychiatric disorders
Contact & Investigator
Tzu Tsun Luk, PhD, RN
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT06061991 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gestational Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06061991 currently recruiting?
Yes, NCT06061991 is actively recruiting participants. Contact the research team at luktt@connect.hku.hk for enrollment information.
Where is the NCT06061991 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong.
Who is sponsoring the NCT06061991 clinical trial?
NCT06061991 is sponsored by The University of Hong Kong. The principal investigator is Tzu Tsun Luk, PhD, RN at The University of Hong Kong. The trial plans to enroll 944 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.